Sunshine Lake Pharma sets board meeting to review interim results, consider dividendPUBT·Aug 19 at 03:35 AM06887+1.46%600673+3.12%
China's Volume‑Based Procurement System Drives Domestic Insulin Supplier to Go GlobalYicai·Aug 14 at 03:52 AM06887+1.46%603707+1.98%
Sunshine Lake Pharma Ships First Interchangeable Insulin Glargine to U.S.Tip Ranks·Jul 31 at 05:42 AM06887+1.46%
Guangdong HEC Pharma wins China NMPA approval for insulin degludec injectionPUBT·Jul 30 at 06:57 AM06887+1.46%
Guangdong HEC Pharma controlling shareholder Zhang lifts stake to 51.42% after buying 1,451,400 H shares for HK$56 millionPUBT·Jul 30 at 06:40 AM06887+1.46%
Guangdong HEC Pharma files HKEX next-day return disclosing share repurchase at HKD 33.82PUBT·Jul 27 at 07:07 AM06887+1.46%
Guangdong HEC Pharma files HKEX next-day disclosure return on share repurchase at HKD 32.34PUBT·Jul 24 at 05:40 AM06887+1.46%
Sunshine Lake Pharma Chairman Boosts Stake as Company Launches Share BuybackTip Ranks·Jul 20 at 10:08 AM06887+1.46%
Guangdong HEC Pharma controlling shareholder Zhang Yushuai holds 51.11% stake, plans HK$300 million-HK$600 million share buy-upPUBT·Jul 20 at 09:46 AM06887+1.46%
Sunshine Lake Pharma Backs RMB2 Billion Healthcare and AI Venture FundTip Ranks·Jun 26 at 10:19 AM600673+3.12%06887+1.46%
Sunshine Lake Pharma to buy Zhejiang industrial land use rights for RMB 26.55 millionPUBT·Jun 26 at 09:46 AM06887+1.46%
Sunshine Lake Pharma Wins Hong Kong Approval for Full H Share CirculationTip Ranks·May 6 at 05:08 AM06887+1.46%513700+0.15%
